1. Home
  2. LFMD vs ESPR Comparison

LFMD vs ESPR Comparison

Compare LFMD & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeMD Inc.

LFMD

LifeMD Inc.

N/A

Current Price

$3.89

Market Cap

190.9M

Sector

Health Care

ML Signal

N/A

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

N/A

Current Price

$2.64

Market Cap

793.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFMD
ESPR
Founded
1994
2008
Country
United States
United States
Employees
384
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.9M
793.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LFMD
ESPR
Price
$3.89
$2.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$9.14
$7.60
AVG Volume (30 Days)
1.2M
4.6M
Earning Date
03-09-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$17.76
$0.69
Revenue Next Year
$17.66
$10.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$2.60
$0.73
52 Week High
$15.34
$4.18

Technical Indicators

Market Signals
Indicator
LFMD
ESPR
Relative Strength Index (RSI) 56.30 39.98
Support Level $3.43 $2.37
Resistance Level $4.20 $3.02
Average True Range (ATR) 0.35 0.19
MACD 0.03 0.00
Stochastic Oscillator 54.49 37.04

Price Performance

Historical Comparison
LFMD
ESPR

About LFMD LifeMD Inc.

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: